Gatralimab

DB16528InvestigationalProtein Based Therapies

Gatralimab is under investigation in clinical trial NCT02389452 (Study of Safety and Efficacy of 6 Ml Synvisc-one (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial...

Mechanism: Pharmacologically active on CAMPATH-1 antigen
Curator reviewed
Code names: GZ-402662

Resolves to

Compound

UNII87MNT78TAZCAS1826020-80-7

Targets

P31358CD52

What you can answer from here — as of July 14, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Gatralimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account